Deborah Bauwens

609 total citations
9 papers, 469 citations indexed

About

Deborah Bauwens is a scholar working on Genetics, Pathology and Forensic Medicine and Biomedical Engineering. According to data from OpenAlex, Deborah Bauwens has authored 9 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Pathology and Forensic Medicine and 3 papers in Biomedical Engineering. Recurrent topics in Deborah Bauwens's work include Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Viral-associated cancers and disorders (2 papers). Deborah Bauwens is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Viral-associated cancers and disorders (2 papers). Deborah Bauwens collaborates with scholars based in Belgium, United States and France. Deborah Bauwens's co-authors include James W. Mimbs, Burton E. Sobel, M. O’Donnell, J G Miller, Matthew O’Donnell, Lucienne Michaux, Philippe Hantson, Pierre‐François Laterre, Dominique Latinne and Marianne de Tourtchaninoff and has published in prestigious journals such as Blood, Circulation Research and British Journal of Haematology.

In The Last Decade

Deborah Bauwens

9 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Bauwens Belgium 8 236 177 152 67 61 9 469
Andrew Needles Canada 11 378 1.6× 439 2.5× 144 0.9× 96 1.4× 5 0.1× 15 701
Chuxiong Ding United States 13 186 0.8× 131 0.7× 64 0.4× 17 0.3× 42 0.7× 38 529
J.-D. Laredo France 13 110 0.5× 150 0.8× 17 0.1× 64 1.0× 179 2.9× 20 929
Mara Bonardi Italy 9 175 0.7× 121 0.7× 41 0.3× 28 0.4× 22 0.4× 13 313
B Ejbjerg Denmark 13 75 0.3× 38 0.2× 75 0.5× 7 0.1× 46 0.8× 24 940
S. Scott Lollis United States 11 188 0.8× 248 1.4× 68 0.4× 16 0.2× 17 0.3× 19 546
Todd Belcik United States 16 469 2.0× 359 2.0× 499 3.3× 5 0.1× 33 0.5× 33 994
Przemysław Palka Australia 19 489 2.1× 79 0.4× 897 5.9× 7 0.1× 12 0.2× 45 1.2k
Deniz Çebi Olgun Türkiye 13 228 1.0× 102 0.6× 22 0.1× 42 0.6× 43 0.7× 29 496
Pernilla Peterson Sweden 12 151 0.6× 19 0.1× 71 0.5× 56 0.8× 12 0.2× 23 473

Countries citing papers authored by Deborah Bauwens

Since Specialization
Citations

This map shows the geographic impact of Deborah Bauwens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Bauwens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Bauwens more than expected).

Fields of papers citing papers by Deborah Bauwens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Bauwens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Bauwens. The network helps show where Deborah Bauwens may publish in the future.

Co-authorship network of co-authors of Deborah Bauwens

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Bauwens. A scholar is included among the top collaborators of Deborah Bauwens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Bauwens. Deborah Bauwens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Knoops, Laurent, Timothy Devos, Yves Béguin, et al.. (2016). The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study. Clinical Biochemistry. 50(7-8). 452–454. 17 indexed citations
2.
Lebras, Laure, Deborah Bauwens, Françoise Berger, et al.. (2013). Early stage follicular lymphoma: what is the clinical impact of the first-line treatment strategy?. Journal of Hematology & Oncology. 6(1). 45–45. 28 indexed citations
3.
Michallet, Anne‐Sophie, et al.. (2012). Early Stage Follicular Lymphoma: Is There a Clinical Impact of First Line Treatment?. Blood. 120(21). 2722–2722. 1 indexed citations
4.
Vekemans, Marie‐Christiane, Michel Delforge, Chantal Doyen, et al.. (2010). The t(14;20)(q32;q12): a rare cytogenetic change in multiple myeloma associated with poor outcome. British Journal of Haematology. 149(6). 901–904. 8 indexed citations
5.
Bauwens, Deborah, Marie Maerevoet, Lucienne Michaux, et al.. (2005). Activity and safety of combined rituximab with chlorambucil in patients with mantle cell lymphoma. British Journal of Haematology. 131(3). 338–340. 24 indexed citations
6.
Bauwens, Deborah, Philippe Hantson, Pierre‐François Laterre, et al.. (2005). Recurrent seizure and sustained encephalopathy associated with dimethylsulfoxide-preserved stem cell infusion. Leukemia & lymphoma. 46(11). 1671–1674. 35 indexed citations
7.
Mimbs, James W., et al.. (1981). Effects of myocardial ischemia on quantitative ultrasonic backscatter and identification of responsible determinants.. Circulation Research. 49(1). 89–96. 114 indexed citations
8.
Mimbs, James W., et al.. (1980). The dependence of ultrasonic attenuation and backscatter on collagen content in dog and rabbit hearts.. Circulation Research. 47(1). 49–58. 155 indexed citations
9.
O’Donnell, M., Deborah Bauwens, James W. Mimbs, & J G Miller. (1979). Broadband Integrated Backscatter: An Approach to Spatially Localized Tissue Characterization in Vivo. 175–178. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026